Unicycive Therapeutics (UNCY) Return on Capital Employed (QoQ) (2021 - 2026)
Unicycive Therapeutics (UNCY) Return on Capital Employed (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Unicycive Therapeutics | 151.01 Mn | 151.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,201.00 |
| Mar 31, 2026 | -353.00 |
| Dec 31, 2025 | 2,071.00 |
| Sep 30, 2025 | 8,162.00 |
| Jun 30, 2025 | 3,757.00 |
| Mar 31, 2025 | 5,662.00 |
| Dec 31, 2024 | -19,839.00 |
| Sep 30, 2024 | -1,217.00 |
| Jun 30, 2024 | 77,614.00 |
| Mar 31, 2024 | -375,299.00 |
| Dec 31, 2023 | 324,222.00 |
| Sep 30, 2023 | -14,512.00 |
| Jun 30, 2023 | -215,131.00 |
| Mar 31, 2023 | 251,144.00 |
| Dec 31, 2022 | -30,267.00 |
| Sep 30, 2022 | -13,127.00 |
| Jun 30, 2022 | -4,847.00 |
| Mar 31, 2022 | -2,703.00 |
| Dec 31, 2021 | 2,028.00 |